Učitavanje...

Lysostaphin Treatment of Experimental Methicillin-Resistant Staphylococcus aureus Aortic Valve Endocarditis

The emergence of clinical isolates of methicillin-resistant Staphylococcus aureus with reduced susceptibility to vancomycin has prompted a search for new and novel therapeutic agents active against S. aureus. Lysostaphin, a peptidase produced by Staphylococcus simulans, specifically cleaves the glyc...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Climo, Michael W., Patron, Roberto L., Goldstein, Beth P., Archer, Gordon L.
Format: Artigo
Jezik:Inglês
Izdano: American Society for Microbiology 1998
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC105603/
https://ncbi.nlm.nih.gov/pubmed/9624475
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!